The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.
Clinical trial NCT06601010 · RECRUITING
Trial details
- NCT number
- NCT06601010
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-09-24
- Primary completion
- 2026-07-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.